[Department Memorandum No. 2021- 0199] Health Technology Assessment Council’s (HTAC) Recommendations on COVID-19 heath technologies
[Department Memorandum No. 2021- 0158] Inclusion of 0.1% Sodium Hyaluronate (15 ml) and 2.5% Peritoneal Dialysis Solution (2L and 5L) in the Philippine National Formulary
[Department Circular No. 2021- 0079] Health Technology Assessment Council’s (HTAC) Recommendations on health technologies requiring Full Certificate of Registration (CPR) from the Food and Drug Administration
[Department Memorandum No. 2021- 0075] Compliance to dissemination of the recommendations of the Health Technology Assessment council (HTAC)
[Department Memorandum No. 2021- 0097] Health Technology Assessment Council’s (HTAC) Recommendations on COVID-19 heath technologies
[Memo to DOH Internal Offices] Acknowledgement of Comments_Concurrence on COVID-19 Vaccines Evaluation Framework
[Department Memorandum No. 2021- 0079] Endorsement of Topic Submissions from National Health Programs for HTA
MEMO ON THE ACCEPTANCE OF MINOR INCLUSIONS IN THE PHILIPPINE NATIONAL FORMULARY (PNF) FOR HEALTH TECHNOLOGY ASSESSMENT (HTA) FOLLOWING THE PNF SYSTEM FOR DRUGS
